Carter Robert Ross sold TOI
January 6, 2025 · Form 4 insider transaction
Carter Robert Ross sold 258 shares of Starling Oncology Inc at $0.34 per share, a transaction worth $86.43. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.; Price is the volume weighted average selling price of all sales by the Reporting Person on January 6, 2025 within a one-dollar range. Actual prices ranged from $0.293 to $0.335. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.